These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3912232)

  • 61. Possible role of some groups in the structure and function of HIV-1 protease as revealed by molecular modeling studies.
    Pechik IV; Gustchina AE; Andreeva NS; Fedorov AA
    FEBS Lett; 1989 Apr; 247(1):118-22. PubMed ID: 2651158
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An artificial aspartic proteinase system.
    Jiang L; Liu Z; Liang Z; Gao Y
    Bioorg Med Chem; 2005 Jun; 13(11):3673-80. PubMed ID: 15862996
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
    Kuzmic P; Sun CQ; Zhao ZC; Rich DH
    Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
    [No Abstract]   [Full Text] [Related]  

  • 64. Pleureryn, a novel protease from fresh fruiting bodies of the edible mushroom Pleurotus eryngii.
    Wang H; Ng TB
    Biochem Biophys Res Commun; 2001 Dec; 289(3):750-5. PubMed ID: 11726212
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV.
    Hof F; Schütz A; Fäh C; Meyer S; Bur D; Liu J; Goldberg DE; Diederich F
    Angew Chem Int Ed Engl; 2006 Mar; 45(13):2138-41. PubMed ID: 16502446
    [No Abstract]   [Full Text] [Related]  

  • 67. Aspartyl proteinase from cucumber (Cucumis sativus) seeds. Preparation and characteristics.
    Wilimowska-Pelc A; Polanowski A; Kołaczkowska MK; Wieczorek M; Wilusz T
    Acta Biochim Pol; 1983; 30(1):23-31. PubMed ID: 6346762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Various aspects of structural studies of aspartate proteinases].
    Andreeva NS; Gushchina AE; Zhdanov AS; Pechik IV; Safro MG; Fedorov AA
    Mol Biol (Mosk); 1989; 23(6):1523-34. PubMed ID: 2698993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of oxygen nucleophiles in tetrahedral intermediates: 2H and 18O induced isotope shifts in 13C NMR spectra of pepsin-bound peptide ketone pseudosubstrates.
    Schmidt PG; Holladay MW; Salituro FG; Rich DH
    Biochem Biophys Res Commun; 1985 Jun; 129(2):597-602. PubMed ID: 3925948
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Kinetic study on the interaction of Rhizopus chinensis aspartic protease with Streptomyces pepsin inhibitor (acetylpepstatin).
    Nakatani H; Hiromi K; Kitagishi K
    Arch Biochem Biophys; 1988 Jun; 263(2):311-4. PubMed ID: 3288122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aspartic proteinases: their activation and structural studies.
    Turk V; Puizdar V; Lah T; Kregar I
    Prog Clin Biol Res; 1982; 102 Pt C():75-86. PubMed ID: 6762543
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.
    Boss C; Corminboeuf O; Grisostomi C; Meyer S; Jones AF; Prade L; Binkert C; Fischli W; Weller T; Bur D
    ChemMedChem; 2006 Dec; 1(12):1341-5. PubMed ID: 17091526
    [No Abstract]   [Full Text] [Related]  

  • 73. Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.
    Blum A; Böttcher J; Sammet B; Luksch T; Heine A; Klebe G; Diederich WE
    Bioorg Med Chem; 2008 Sep; 16(18):8574-86. PubMed ID: 18760609
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
    Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
    Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin.
    James MN; Hsu IN; Delbaere LT
    Nature; 1977 Jun; 267(5614):808-13. PubMed ID: 895839
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular model for the binary complex of uropepsin and pepstatin.
    de Azevedo WF; Canduri F; Fadel V; Teodoro LG; Hial V; Gomes RA
    Biochem Biophys Res Commun; 2001 Sep; 287(1):277-81. PubMed ID: 11549287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Role of water molecules located near the active center of aspartic proteinases].
    Kashparov IA; Popov ME; Andreeva NS
    Mol Biol (Mosk); 1997; 31(6):1030-5. PubMed ID: 9480416
    [No Abstract]   [Full Text] [Related]  

  • 79. The catalytic mechanism of aspartic proteinases.
    Pearl LH
    FEBS Lett; 1987 Apr; 214(1):8-12. PubMed ID: 3552727
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Denaturation studies of aspartic proteinases.
    Pain RH; Lah T; Turk V
    Biochem Soc Trans; 1985 Dec; 13(6):1032-5. PubMed ID: 3937750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.